| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |